Comparison of Carotid Intima Media Thickness in Children of Patients with and without Premature Coronary Artery Disease.

INTRODUCTION: Increased Carotid Intima Medial Thickness (CIMT) is associated with cardiovascular risk factors and vascular events like Coronary Artery Disease (CAD) and stroke. AIM: This study was designed to identify whether CIMT is increased in the children of parents with premature coronary artery disease and compare it with age and sex matched controls who are children of normal individuals. We also tried to compare and correlate the changes in CIMT if any, among the study group with relation to family history of diabetes and hypertension. MATERIALS AND METHODS: It was an observational prospective case control study. Twenty five cases (children of parents with premature coronary artery disease) were recruited as per the inclusion and exclusion criteria. Age and sex matched controls were recruited from the paediatric Outpatient Department (OPD). The CIMT was measured using ultrasound Doppler as per the protocol by the Mannheim intima media thickness consensus statement. RESULTS: Ten children out of 25 controls had CIMT of 0.05 cm and 5 out of 25 cases had CIMT of 0.07 cm. The association between cases and controls was not statistically significant. Even though the CIMT increases after 10 years, there is no statistically significant association between cases and controls in the different age groups. Out of the total 48% of the children among the case group had family history of hypertension whereas 28% in the control group. A 33% of children in the case group with family history of hypertension had CIMT of 0.07 cm; 46% of children in case group without family history of hypertension had CIMT of 0.05 cm. This difference was statistically significant (p=0.005). There was no significant association between family history of diabetes mellitus and CIMT in both groups. CONCLUSION: There was significant association between CIMT in children with family history of premature CAD and family history of hypertension when compared with no family history of hypertension with premature CAD. There was no significant association between CIMT of children with and without family history of premature CAD.

Antimicrobial activities of a promising glycolipid biosurfactant from a novel marine Staphylococcus saprophyticus SBPS 15.

Biosurfactants have gained a renewed interest in the recent years for their commercial application in diverse research areas. Recent evidences suggest that the antimicrobial activities exhibited by biosurfactants make them promising molecules for the application in the field of therapeutics. Marine microbes are well known for their unique metabolic and functional properties; however, few reports are available till date regarding their biosurfactant production and antimicrobial potential. In an ongoing survey for bioactive microbial metabolites from microbes isolated from diverse ecological niches, a marine Staphylococcus saprophyticus SBPS 15 isolated from the petroleum hydrocarbon contaminated coastal site, Puducherry, India, was identified as a promising biosurfactant producer based on multiple screening methods. This bacterium exhibited growth-dependent biosurfactant production and the recorded yield was 1.345 ± 0.056 g/L (on dry weight basis). The biosurfactant was purified and chemically characterized as a glycolipid with a molecular mass of 606.7 Da, based on TLC, biochemical estimation methods, FT-IR spectrum and MALDI-TOF-MS analysis. Further, the estimated molecular mass was different from the earlier reports on biosurfactants. This new glycolipid biosurfactant exhibited a board range of pH and temperature stability. Furthermore, it revealed a promising antimicrobial activity against many tested human pathogenic bacterial and fungal clinical isolates. Based on these observations, the isolated biosurfactant from the marine S. saprophyticus revealed board physicochemical stabilities and possess excellent antimicrobial activities which proves its significance for possible use in various therapeutic and biomedical applications. To the best of our knowledge, this is the first report of a biosurfactant from the bacterium, S. saprophyticus.

In vitro and in vivo antioxidant potentials of an ethanolic extract of Ganoderma lucidum in rat mammary carcinogenesis.

AIM: Considering the importance of diet in the prevention of cellular damage caused by reactive oxygen species which has been implicated for several diseases, this present study was undertaken to evaluate the in vitro and in vivo antioxidant potential of the ethanolic extract of the fruiting bodies of Ganoderma lucidum on 7, 12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in Sprague Dawley rats. METHODS: Ganoderma lucidum extract was tested for in vitro antioxidant and radical scavenging assays, such as (ABTS(+)) radical cation decolorization assay, DPPH radical scavenging, hydroxyl radical, and superoxide radical scavenging assays. The in vivo antioxidant potentials were analyzed by SOD, CAT, and GPx in plasma, mammary, and liver tissues. RESULTS: In all the in vitro antioxidant and radical scavenging assays the extract exhibited good scavenging activity. In vivo enzymatic antioxidant levels, such as SOD, CAT, and GPx were decreased in DMBA-induced animals. Moreover, pretreatment with G. lucidum (500 mg · kg(-1) bw) to DMBA-induced animals significantly (P < 0.05) increased the levels of SOD, CAT, and GPx in plasma, mammary, and liver tissues compared to DMBA induced animals. CONCLUSIONS: From these findings, it is suggested that G. lucidum extract could be considered as a potential source of natural antioxidants and can be used as an effective chemopreventive agent against mammary cancer.

Preemptive caudal bupivacaine and morphine for postoperative analgesia in children.

UNLABELLED: We designed this double-blind study to evaluate the efficacy of preemptive epidural bupivacaine and small-dose morphine for postoperative analgesia in children after herniorraphy. Sixty children, ASA physical status I or II, who were undergoing elective hernia repair under general anesthesia were randomly allocated into two groups. Group I (preemptive group) received 0.66 mL/kg 0.25% bupivacaine with morphine 0.02 mg/kg caudally after the induction of anesthesia but 15 min before surgery. Group II (postincisional group) received the same drug mixture after surgery. Pain was assessed using an objective pain scale (OPS). Time to first postoperative analgesics (TFA), the number of supplementary analgesic used, and the amount of morphine consumed over the ensuing 24-h period were noted. The OPS score was significantly less in Group I at 0.5, 4, and 8 h (P < 0.05) than in Group II after surgery. The median OPS score recorded over 24 h was 0 for Group I and 2 for Group II, which was significantly different (P < 0.05). The TFA in Group I (12.55 +/- 3.06 h) was significantly (P < 0.05) prolonged compared with Group II (10.62 +/- 3.18 h). The total postoperative morphine consumption in Group I (2.24 +/- 1.4 mg) was significantly (P < 0.05) less than that in Group II (3.34 +/- 2.29 mg). Nevertheless, the incidence of nausea and vomiting was not significantly different between the groups. In this study, we demonstrated that preemptive epidural bupivacaine and small-dose morphine administration is superior to the same mixture given at the conclusion of surgery for pain relief. IMPLICATIONS: This study was performed on two groups of 30 children undergoing hernia repair. Group I received a bupivacaine-morphine mixture caudally before surgery, and Group II received the same drugs caudally at the completion of surgery. Postoperative assessment demonstrated longer and better pain relief in Group I.